Literature DB >> 19793197

Hepatic progenitor cells in liver cancers from Asian children.

Stephen C Ward1, Swan N Thung, Kiat Hon Lim, Tung Thanh Tran, Thi Khang Bui Hong, Phuc Le Hoang, Ja June Jang, Young Nyun Park, Kenji Abe.   

Abstract

BACKGROUND/AIMS: Hepatoblastoma (HB) and hepatocellular carcinoma (HCC) are the two most common primary malignant liver tumours in children. Hepatic progenitor cells have been described and can be stained with K19, EpCAM and CD117. We investigated the morphology and staining patterns of primary liver tumours in Asian children.
METHODS: Four pathologists studied slides from 39 paediatric patients from Vietnam and Korea aged 8 months to 16 years. We performed immunohistochemical stains for K19, EpCAM and CD117, and polymerase chain reaction for tissue hepatitis B virus (HBV) DNA and hepatitis C virus (HCV) RNA.
RESULTS: There was agreement on the diagnosis of 24 cases of HCC and 10 cases of HB (one recurrent case). The diagnosis was split for six cases (HCC/HB). All 20 cases of HCC tested were HBV DNA+ and HCV RNA-. All nine cases of HB tested were HBV DNA-, while one was HCV RNA+. Of four HCC/HB cases tested, three were HBV DNA+ and all were HCV RNA-. By immunohistochemistry, 8/24 (33%) cases of HCC were K19+ and 18/24 (75%) were EpCAM+, 5/10 (50%) cases of HB were K19+ and 7/10 (70%) were EpCAM+ and 3/6 (50%) cases of HCC/HB were K19+ and 5/6 (83%) were EpCAM+. CD117 was negative in all 38 cases tested. Paediatric HCC has a morphology different from adult HCC, sometimes resembling HB, and a larger proportion of paediatric tumours have progenitor cell features.
CONCLUSIONS: HB and HCC in children may represent malignant transformation at an early stage in the cellular lineage and often arise from hepatic progenitor cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19793197     DOI: 10.1111/j.1478-3231.2009.02126.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  5 in total

Review 1.  Role of liver stem cells in hepatocarcinogenesis.

Authors:  Lei-Bo Xu; Chao Liu
Journal:  World J Stem Cells       Date:  2014-11-26       Impact factor: 5.326

Review 2.  Multidrug resistance and cancer stem cells in neuroblastoma and hepatoblastoma.

Authors:  Anna Alisi; William C Cho; Franco Locatelli; Doriana Fruci
Journal:  Int J Mol Sci       Date:  2013-12-18       Impact factor: 5.923

3.  A Transcriptomic Signature of Mouse Liver Progenitor Cells.

Authors:  Adam M Passman; Jasmine Low; Roslyn London; Janina E E Tirnitz-Parker; Atsushi Miyajima; Minoru Tanaka; Helene Strick-Marchand; Gretchen J Darlington; Megan Finch-Edmondson; Scott Ochsner; Cornelia Zhu; James Whelan; Bernard A Callus; George C T Yeoh
Journal:  Stem Cells Int       Date:  2016-10-03       Impact factor: 5.443

4.  Histological and immunohistochemical study of hepatoblastoma: correlation with tumour behaviour and survival.

Authors:  Kala Gnanasekaran Kiruthiga; Banumathi Ramakrishna; Soumitra Saha; Sudipta Sen
Journal:  J Gastrointest Oncol       Date:  2018-04

5.  Targeting EpCAM (CD326) for immunotherapy in hepatoblastoma.

Authors:  Sorin Armeanu-Ebinger; Alexander Hoh; Julia Wenz; Joerg Fuchs
Journal:  Oncoimmunology       Date:  2013-01-01       Impact factor: 8.110

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.